Dapagliflozin

Product NDC
42571-317
11-digit product format
425710317
Labeler code
42571
Product ID
42571-317_5ef6e455-992a-55fe-e063-6394a90a2143
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Dapagliflozin
Dosage form
TABLET
Route
ORAL
Labeler
Micro Labs Limited
Application
ANDA211467
Marketing category
ANDA
Marketing start
2026-10-01
Substance
DAPAGLIFLOZIN
Active strength
5 mg/1
Pharmacologic classes
Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A211467-001DAPAGLIFLOZINDAPAGLIFLOZIN5MGTABLET / ORALAB2026-04-06
A211467-002DAPAGLIFLOZINDAPAGLIFLOZIN10MGTABLET / ORALAB2026-04-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A211467-001AB
A211467-002AB

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 2 matching rows.

Application-product, Exclusivity code, Expiration table
Application-productExclusivity codeExpiration
A211467-001PC2026-10-03
A211467-002PC2026-10-03

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A211467-001DAPAGLIFLOZIN5MGTABLET / ORALAB2026-04-06d4dbc9d85df4…
2026-11-14 07:37:172026-10A211467-002DAPAGLIFLOZIN10MGTABLET / ORALAB2026-04-06d4dbc9d85df4…
2026-10-15 13:18:302026-09A211467-001DAPAGLIFLOZIN5MGTABLET / ORALAB2026-04-06c2088c7a36db…
2026-10-15 13:18:302026-09A211467-002DAPAGLIFLOZIN10MGTABLET / ORALAB2026-04-06c2088c7a36db…
2026-09-14 22:38:342026-08A211467-001DAPAGLIFLOZIN5MGTABLET / ORALAB2026-04-0684e616aacf4f…
2026-09-14 22:38:342026-08A211467-002DAPAGLIFLOZIN10MGTABLET / ORALAB2026-04-0684e616aacf4f…
2026-08-18 06:07:402026-07A211467-001DAPAGLIFLOZIN5MGTABLET / ORALAB2026-04-06caaa826d4ba7…
2026-08-18 06:07:402026-07A211467-002DAPAGLIFLOZIN10MGTABLET / ORALAB2026-04-06caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A211467-001DAPAGLIFLOZIN5MGTABLET / ORALAB2026-04-06a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A211467-002DAPAGLIFLOZIN10MGTABLET / ORALAB2026-04-06a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A211467-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A211467-002AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A211467-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A211467-002AB1c2088c7a36db…
2026-09-14 22:38:342026-08A211467-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A211467-002AB184e616aacf4f…
2026-08-18 06:07:402026-07A211467-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A211467-002AB1caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A211467-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A211467-002AB1a50c72e98297…

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2026-11-14 07:37:172026-10A211467-001PC2026-10-03d4dbc9d85df4…
2026-11-14 07:37:172026-10A211467-002PC2026-10-03d4dbc9d85df4…
2026-10-15 13:18:302026-09A211467-001PC2026-10-03c2088c7a36db…
2026-10-15 13:18:302026-09A211467-002PC2026-10-03c2088c7a36db…
2026-09-14 22:38:342026-08A211467-001PC2026-10-0384e616aacf4f…
2026-09-14 22:38:342026-08A211467-002PC2026-10-0384e616aacf4f…
2026-08-18 06:07:402026-07A211467-001PC2026-10-03caaa826d4ba7…
2026-08-18 06:07:402026-07A211467-002PC2026-10-03caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A211467-001PC2026-10-03a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A211467-002PC2026-10-03a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Dapagliflozin
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DAPAGLIFLOZIN5 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1ULL0QJ8UCInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1488569Internal RxNorm lookup
1488574Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
5dc0e9df-3b45-4469-93fe-3d2eddbfe2b7Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DapagliflozinDAPAGLIFLOZINMicro Labs Limited5dc0e9df-3b45-4469-93fe-3d2eddbfe2b72026-10-29Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211467
application number: ANDA211467
ndc (product): 42571-317

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
42571-317-10425710317101000 TABLET in 1 BOTTLE (42571-317-10) 1000 tablet2026-10-01NoNoCurrent
42571-317-304257103173030 TABLET in 1 BOTTLE (42571-317-30) 30 tablet2026-10-01NoNoCurrent
42571-317-904257103179090 TABLET in 1 BOTTLE (42571-317-90) 90 tablet2026-10-01NoNoCurrent